Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Somatic coding mutations in human induced pluripotent stem cells


Defined transcription factors can induce epigenetic reprogramming of adult mammalian cells into induced pluripotent stem cells. Although DNA factors are integrated during some reprogramming methods, it is unknown whether the genome remains unchanged at the single nucleotide level. Here we show that 22 human induced pluripotent stem (hiPS) cell lines reprogrammed using five different methods each contained an average of five protein-coding point mutations in the regions sampled (an estimated six protein-coding point mutations per exome). The majority of these mutations were non-synonymous, nonsense or splice variants, and were enriched in genes mutated or having causative effects in cancers. At least half of these reprogramming-associated mutations pre-existed in fibroblast progenitors at low frequencies, whereas the rest occurred during or after reprogramming. Thus, hiPS cells acquire genetic modifications in addition to epigenetic modifications. Extensive genetic screening should become a standard procedure to ensure hiPS cell safety before clinical use.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: hiPS cells acquired protein-coding somatic mutations.

Similar content being viewed by others

Accession codes

Primary accessions

Sequence Read Archive

Data deposits

Sequencing results for the mutations reported here are included in Supplementary Figure 1. Raw Illumina sequencing reads are available from the NCBI ShortRead Archive, accession SRP005709, except for lines derived from Hib11, Hib17, Hib29, CF, HFFxF, dH1F fibroblasts as the original donors were not consulted about public release of their genome data.


  1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006)

    Article  CAS  Google Scholar 

  2. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007)

    Article  ADS  CAS  Google Scholar 

  3. Mayshar, Y. et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7, 521–531 (2010)

    Article  CAS  Google Scholar 

  4. Hong, H. et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway. Nature 460, 1132–1135 (2009)

    Article  ADS  CAS  Google Scholar 

  5. Li, H. et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136–1139 (2009)

    Article  ADS  CAS  Google Scholar 

  6. Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140–1144 (2009)

    Article  ADS  CAS  Google Scholar 

  7. Utikal, J. et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460, 1145–1148 (2009)

    Article  ADS  CAS  Google Scholar 

  8. Marión, R. M. et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149–1153 (2009)

    Article  ADS  Google Scholar 

  9. Ruiz, S. et al. A high proliferation rate is required for somatic cell reprogramming and maintenance of human embryonic stem cell identity. Curr. Biol. 21, 45–52 (2011)

    Article  CAS  Google Scholar 

  10. Porreca, G. J. et al. Multiplex amplification of large sets of human exons. Nature Methods 4, 931–936 (2007)

    Article  CAS  Google Scholar 

  11. Deng, J. et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nature Biotechnol. 27, 353–360 (2009)

    Article  CAS  Google Scholar 

  12. Bashiardes, S. et al. Direct genomic selection. Nature Methods 2, 63–69 (2005)

    Article  CAS  Google Scholar 

  13. Gnirke, A. et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nature Biotechnol. 27, 182–189 (2009)

    Article  CAS  Google Scholar 

  14. Levy, S. et al. The diploid genome sequence of an individual human. PLoS Biol. 5, e254 (2007)

    Article  Google Scholar 

  15. Drmanac, R. et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 327, 78–81 (2009)

    Article  ADS  Google Scholar 

  16. Ng, S. B. et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461, 272–276 (2009)

    Article  ADS  CAS  Google Scholar 

  17. Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protocols 4, 1073–1081 (2009)

    Article  CAS  Google Scholar 

  18. Forbes, S. A. et al. The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr. Protocols Hum. Genet. 10, 10.11 (2008)

    Google Scholar 

  19. Shah, S. P. et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809–813 (2009)

    Article  ADS  CAS  Google Scholar 

  20. Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177–183 (2004)

    Article  CAS  Google Scholar 

  21. Hamosh, A., Scott, A. F., Amberger, J. S., Bocchini, C. A. & McKusick, V. A. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 33, D514–D517 (2005)

    Article  CAS  Google Scholar 

  22. Druley, T. E. et al. Quantification of rare allelic variants from pooled genomic DNA. Nature Methods 6, 263–265 (2009)

    Article  CAS  Google Scholar 

  23. Ahuja, D., Saenz-Robles, M. T. & Pipas, J. M. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24, 7729–7745 (2005)

    Article  CAS  Google Scholar 

  24. Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797–801 (2009)

    Article  ADS  CAS  Google Scholar 

  25. Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191–196 (2010)

    Article  ADS  CAS  Google Scholar 

  26. Lee, W. et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465, 473–477 (2010)

    Article  ADS  CAS  Google Scholar 

  27. Ding, L. et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999–1005 (2010)

    Article  ADS  CAS  Google Scholar 

  28. Dennis, G., Jr et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, P3 (2003)

    Article  Google Scholar 

  29. Lee, J. H. et al. A robust approach to identifying tissue-specific gene expression regulatory variants using personalized human induced pluripotent stem cells. PLoS Genet. 5, e1000718 (2009)

    Article  Google Scholar 

  30. Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008)

    Article  ADS  CAS  Google Scholar 

  31. Chan, E. M. et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nature Biotechnol. 27, 1033–1037 (2009)

    Article  CAS  Google Scholar 

  32. Dimos, J. T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218–1221 (2008)

    Article  ADS  CAS  Google Scholar 

  33. Rodriguez-Piza, I. et al. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions. Stem Cells 28, 36–44 (2010)

    CAS  PubMed  Google Scholar 

  34. Aasen, T. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotechnol. 26, 1276–1284 (2008)

    Article  CAS  Google Scholar 

  35. Stewart, S. A. et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9, 493–501 (2003)

    Article  CAS  Google Scholar 

  36. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618–630 (2010)

    Article  CAS  Google Scholar 

  37. Akagi, T., Sasai, K. & Hanafusa, H. Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc. Natl Acad. Sci. USA 100, 13567–13572 (2003)

    Article  ADS  CAS  Google Scholar 

  38. Cowan, C. A. et al. Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353–1356 (2004)

    Article  CAS  Google Scholar 

  39. Boulting, G. L. et al. A functionally characterized test set of human induced pluripotent stem cells. Nature advance online publication. 10.1038/nbt.1783 (3 February 2011)

  40. Zhang, K. et al. Digital RNA allelotyping reveals tissue-specific and allele-specific gene expression in human. Nature Methods 6, 613–618 (2009)

    Article  CAS  Google Scholar 

  41. Meena Kishore, S., Vincent, T. K. C. & Pandjassarame, K. Distributions of exons and introns in the human genome. In Silico Biol. 4, 387–393 (2004)

    Google Scholar 

Download references


We thank J. M. Akey, G. M. Church, S. Ding, J. B. Li and J. Shendure for discussions and suggestions, S. Vassallo for assistance with DNA shearing, and G. L. Boulting and S. Ratansirintrawoot for assistance with hiPS cell culture. This study is supported by NIH R01 HL094963 and a UCSD new faculty start-up fund (to K.Z.), a training grant from the California Institute for Regenerative Medicine (TG2-01154) and a CIRM grant (RC1-00116) (to L.S.B.G.). L.S.B.G. is an Investigator of the Howard Hughes Medical Institute. A. Gore is supported by the Focht-Powell Fellowship and a CIRM predoctoral fellowship. M.L.W. is supported by an institutional training grant from the National Institute of General Medical Sciences (T32 GM008666). Y.-H.L. is supported by the A*Star Institute of Medical Biology and the Singapore Stem Cell Consortium. Work in the laboratory of J.C.I.B. was supported by grants from MICINN, Sanofi-Aventis, the G. Harold and Leila Y. Mathers Foundation and the Cellex Foundation. G.Q.D. is an investigator of the Howard Hughes Medical Institute and supported by grants from the NIH.

Author information

Authors and Affiliations



L.S.B.G. and K.Z. co-directed the study. A. Gore, Z.L., L.S.B.G. and K.Z. designed the experiments. J.E.Y., S.A., J.A.-B., I.C., A. Giorgetti, M.A.I., E.K., J.-H.L., Y.-H.L., P.D.M., N.M., A.D.P., S.R., M.L.W., J. Yu, J.C.I.B., D.J.R., J.A.T., K.E., G.Q.D. and L.S.B.G. biopsied, cultured and derived hiPS cell lines. Z.L. performed DNA extraction. A. Gore, Z.L. and K.Z. performed exome library construction, DigiQ library construction and validation Sanger sequencing. H.-L.F. performed Illumina sequencing. A. Gore and K.Z. performed bioinformatic and statistical analysis with contributions from E.F.K. A. Gore, Z.L., L.S.B.G., G.Q.D. and K.Z. wrote the manuscript with contributions from all other authors.

Corresponding authors

Correspondence to Lawrence S. B. Goldstein or Kun Zhang.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

The file contains Supplementary Figures 1-5 with legends and a Supplementary Note. (PDF 8937 kb)

Supplementary Tables

The file contains Supplementary Tables 1-3 (XLS 73 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gore, A., Li, Z., Fung, HL. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63–67 (2011).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer